NCT05646290

Completed

Validation of a Model for Predicting Anastomotic Leakage

Jichao Qin Source

Compare

Other study identifiers

Sponsor study identifier

TJ-IRB20211255

Study Type

observational

Actual enrollment (reported)

512

Locations

1 country

Sites

1

Timeline

Study Start

January 6, 2022

Actual (reported)

Primary Completion

March 15, 2024

Actual (reported)

Study Completion

May 6, 2024

Actual (reported)

Brief Summary

This study will validate a machine learning model for predicting anastomotic leakage of esophagogastrostomy and esophagojejunostomy.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 512 participants
Study completion date: May 6, 2024
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 6, 2022
Actual (reported)
First Submitted
December 1, 2022
Actual (reported)
First Posted
December 12, 2022
Actual (reported)
Primary Completion
March 15, 2024
Actual (reported)
Study Completion
May 6, 2024
Actual (reported)

Last Updated: November 21, 2024
Status Verified: November 2024
Last Update Submitted: November 18, 2024

Conditions

Gastric Cancer

Keywords

machine learninganastomotic leakagetotal and proximal gastrectomy

Outcome Measures

Primary Outcomes (1)

Incidence of anastomotic leakage
Within 30 days after operation

Eligibility Criteria

Age18 Years - 85 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Gastric cancer patients undergoing total or proximal gastrectomy in five medical centers (Tongji Hospital, Wuhan No. 1 Hospital, Xianning Central Hospital, Huanggang Central Hospital and Jingzhou Central Hospital) are included in this perspective study.

You may qualify if:

Aged older than 18 years and younger than 85 years.

Sponsors & Collaborators

Jichao Qin
Otherlead

Study Sites (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology

Wuhan, Hubei, 430030, China

MeSH Terms

Conditions

Stomach NeoplasmsAnastomotic Leak

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Enrollment

512 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR INVESTIGATOR
PI Title: Professor

Study Record Dates

First Submitted

December 1, 2022

First Posted

December 12, 2022

Study Start

January 6, 2022

Actual (reported)

NCT05301699

Development and Validation of a Web-based Nomorgam to Predict Postoperative Complications

Completed

NCT04947995

Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer

Unknown

NCT06354036

Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy

Not ApplicableUnknown

NCT05465512

Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy

Completed

NCT06383793

Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy

Unknown

NCT04850716

Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer

Unknown

Primary gastric adenocarcinoma confirmed by preoperative pathology.

Expected curative resection via total or proximal gastrectomy.

American Society of Anesthesiologists (ASA) class I, II, or III.

Written informed consent.

You may not qualify if:

Pregnant or breastfeeding women.
Severe mental disorder or language communication disorder.
Other surgical procedures of gastrectomy is performed.
Interrupted of surgery for more than 30 minutes due to any cause.
Malignant tumors with other organs

Contact the study team to confirm eligibility.

Primary Completion

March 15, 2024

Actual (reported)

Study Completion

May 6, 2024

Actual (reported)

Last Updated

November 21, 2024

Record last verified: 2024-11

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT05646290
Data provider: ClinicalTrials.gov
Source updated: 2024-11-21
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:29:51 UTC

Locations

CN(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations